Related Experiment Video
Updated: May 16, 2026

10:58
Protein WISDOM: A Workbench for In silico De novo Design of BioMolecules
Published on: July 25, 2013
Design requirements for interfering particles to maintain coadaptive stability with HIV-1
Igor M Rouzine1, Leor S Weinberger
1The Gladstone Institutes, San Francisco, California, USA.
Journal of Virology
|December 11, 2012
Summary
Engineered defective interfering particles (DIPs) show promise for treating human immunodeficiency virus (HIV). Mathematical modeling suggests DIPs competing for capsids, not genome codimerization, offer evolutionary stability against HIV-1 evolution.
Area of Science:
- Virology
- Evolutionary Biology
- Computational Biology
Background:
- Defective interfering particles (DIPs) are viral mutants that parasitize wild-type viruses.
- Engineered DIPs are explored as potential therapies for diseases like HIV.
- Lentiviruses, such as HIV, exhibit high mutation rates and within-host diversity, raising questions about DIP therapy efficacy.
Purpose of the Study:
- To investigate the evolutionary stability of DIPs in the context of HIV-1.
- To identify molecular characteristics required for coadaptive stability between HIV-1 and DIPs.
- To assess potential evolutionary hurdles for DIP-based HIV therapies.
Main Methods:
- Utilized a mathematical model simulating HIV-1 replication within a host, including DIP interference.
- Calculated evolutionary selection coefficients to predict the stability of different DIP interference mechanisms.
- Analyzed the impact of capsid competition and genome codimerization on evolutionary dynamics.
Main Results:
- Interference via genome codimerization between DIPs and HIV-1 is predicted to be evolutionarily unstable, with selection against recombination.
- DIPs interfering through competition for capsids demonstrate potential for evolutionary stability if the HIV-1 capsid-to-genome ratio exceeds 1.
- HIV-1 variants attempting to evade interference by starving DIPs are predicted to be selected against.
Conclusions:
- The study provides insights into the apparent absence of natural lentiviral DIPs.
- It suggests that engineered DIPs interfering via capsid competition could be evolutionarily robust for HIV therapy.
- The findings guide experimental approaches to validate these predictions and refine therapeutic strategies.
More Related Videos
Related Concept Videos
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...

